Merck & Co. tested its Gardasil vaccine so it can seek approval to market the vaccine for two new uses, blocking cervical cancer in women over age 26 and preventing anal cancer in homosexual men.

Investing.com -- Merck & Co (NYSE:MRK), the New Jersey-based pharmaceutical giant, has announced a halt in shipments of its ...

A federal judge ruled in Merck & Co.’s favor in a safety lawsuit over its Gardasil vaccine, allowing the drugmaker to ...

Two of the strains that Gardasil protects against, HPV 16 and HPV 18, are responsible for approximately 70 percent of all cervical, vaginal, vulvar and anal cancers.

Perry's U-turn on Gardasil is a step-change to the right: Despite the cynicism and bag-running involved in the 2007 decision to mandate HPV vaccines for girls, it will save lives.

Recipients of Merck & Co.'s Gardasil cervical-cancer vaccine had higher rates of fainting and blood clots than those receiving other vaccines, but it doesn't appear to raise the risk of certain ...

U.S. regulators approved a new Merck & Co. vaccine that is designed to offer broader protection than existing vaccines against cervical cancer and other cancers caused by a sexually transmitted ...

She was so hopeful, even tellineg me that the disease as we know it would be eradicated completely in 20 years thanks to Gardasil. To read that only 20-30% of the population is getting vaccinated ...

Gardasil is Merck & Co.’s (MRK) leading vaccine franchise. Gardasil is a vaccine for the prevention of certain strains of HPV (human papillomavirus), a sexually transmitted disease. Total sales ...

Merck & Co. has been experiencing a surging wave of Gardasil sales that it expects to ride for some time yet. To maintain the momentum, the drugmaker says it will spend $1 billion to expand ...

The continued decline of Merck & Co.’s HPV vaccine Gardasil in China has come to a head as the New Jersey drug giant is halting shipments to the world’s second-most populous country.